| Title | Announcement Number | Activity Code | Clinical Trials Status | Expiration Date Sort descending | Program Official |
|---|---|---|---|---|---|
| Cancer Prevention and Control Clinical Trials Grant Program | PAR-25-167 (R01 Clinical Trial Required) | R01 | Clinical Trial Required | 01/08/2027 | |
| HEAL Initiative: Studies to Enable Analgesic Discovery | RFA-NS-25-023 (R61/R33 - Clinical Trial Not Allowed) | R61, R33 | Clinical Trial Not Allowed | 01/16/2027 | Rachel Altshuler, Ph.D. |
| Cancer Prevention and Control Clinical Trials Planning Grant Program | PAR-25-104 (R34 Clinical Trials Optional) | R34 | 10/26/2027 | Goli Samimi, Ph.D., M.P.H. | |
| Cancer Prevention and Control Clinical Trials Planning Grant Program | PAR-25-103 (U34 Clinical Trials Optional) | U34 | 10/26/2027 | Brandy Heckman-Stoddard, Ph.D., M.P.H. | |
| Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies | PAR-25-145 (R01 Clinical Trial Optional) | R01 | Clinical Trial Optional | 01/08/2028 | Rachel Altshuler, Ph.D. |
